Epidemiology of Cervical Cancer and Contributing Factors in HIV-Positive Women Attending Public Hospitals in Amhara Region, Ethiopia: A Cross-Sectional Analysis for 2025 - Report - MDSpire

Epidemiology of Cervical Cancer and Contributing Factors in HIV-Positive Women Attending Public Hospitals in Amhara Region, Ethiopia: A Cross-Sectional Analysis for 2025

  • By

  • Muluken Belachew Mengistie

  • Wubete Lule Ayalew

  • Simane Kefale Mengistie

  • Ayenew Sisay Gebeyehu

  • Sefefe Birhanu Tizie

  • Ashagrie Anteneh Mekonen

  • Mezigebu Lule Ayalew

  • February 28, 2026

  • 0 min

Share

Epidemiology of Cervical Cancer and Contributing Factors in HIV-Positive Women

Overview

Cervical cancer poses a significant health risk to women living with HIV in Ethiopia, with high incidence rates linked to HPV infection. This study highlights the urgent need for improved screening and prevention strategies in this vulnerable population.

Background

Cervical cancer is a leading cause of cancer-related mortality among women, particularly in low-income countries where screening is inadequate. Women living with HIV are at an elevated risk due to immunosuppression, which facilitates the progression of HPV infections to cervical cancer. Understanding the epidemiology of cervical cancer in this group is crucial for developing effective public health interventions.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

Incorporate specific statistics related to cervical cancer incidence in Ethiopia.

Clinical Implications

Healthcare providers should prioritize regular cervical cancer screening for women living with HIV, as they are at increased risk. Implementing HPV vaccination and enhancing screening programs are critical steps in reducing the burden of cervical cancer in this population.

Conclusion

Cervical cancer remains a preventable disease, yet significant barriers to screening and treatment persist, particularly among women living with HIV in Ethiopia. Addressing these challenges is vital for improving health outcomes in this high-risk group.

References

  1. World Health Organization, WHO, 2025 -- Cervical cancer
  2. Open Forum Infectious Diseases, 2025 -- Worldwide Assessment of the Burden of HPV-Associated Noncervical Cancers in Individuals with HIV and AIDS
  3. The Journal of Infectious Diseases, 2025 -- Case-Control Study of Cervicovaginal β/γ–Human Papillomavirus Infection in Women With Human Immunodeficiency Virus
  4. Open Forum Infectious Diseases — Anal Cancer Incidence Among South African Men and Women With and Without HIV Infection
  5. The Journal of Infectious Diseases — Exploring Trends in HPV-Associated Cancers in Norway: A Focus Beyond Women's Health
  6. International Papillomavirus Society policy statement on HPV-based cervical cancer screening for women living with HIV
  7. Immunogenicity and safety of two versus three doses of 9-valent vaccine against HPV in women with HIV
  8. Cervical cancer

Original Source(s)

Related Content